🔗 Share this article

The prestigious award in medical science was awarded for revolutionary findings that illuminate how the immune system targets dangerous infections while sparing the body's own cells.

A trio of esteemed scientists—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their work identified unique "security guards" within the immune system that remove rogue defense cells that could attacking the organism.

The discoveries are now paving the way for innovative therapies for immune disorders and malignancies.

The winners will share a monetary award worth 11 million Swedish kronor.

Crucial Findings

"The research has been decisive for comprehending how the immune system operates and why we do not all develop serious autoimmune diseases," commented the chair of the Nobel Committee.

This trio's studies address a core question: How does the defense system protect us from numerous infections while leaving our healthy cells intact?

The body's protection system uses immune cells that search for indicators of infection, including pathogens and bacteria it has never encountered.

These cells utilize sensors—called receptors—that are produced by chance in a vast number of combinations.

This gives the defense network the ability to fight a broad range of invaders, but the randomness of the process unavoidably produces immune cells that can target the host.

Security Guards of the Body

Researchers previously knew that a portion of these problematic white blood cells were destroyed in the thymus—the site where white blood cells develop.

This year's award recognizes the discovery of T-reg cells—described as the immune system's "peacekeepers"—which travel through the system to disarm any immune cells that assault the healthy cells.

We know that this process fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

A prize committee stated, "These findings have laid the foundation for a novel area of investigation and accelerated the creation of new therapies, for instance for tumors and immune disorders."

In cancer, T-regs block the system from fighting the tumor, so studies are aimed at reducing their quantity.

In self-attack disorders, trials are testing boosting regulatory T-cells so the body is not being harmed. A comparable method could also be useful in minimizing the risks of organ transplant failure.

Innovative Experiments

Prof Shimon Sakaguchi, from Osaka University, conducted experiments on mice that had their thymus removed, leading to autoimmune disease.

The researcher demonstrated that introducing defense cells from healthy mice could prevent the illness—suggesting there was a mechanism for blocking defenders from harming the host.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic immune disorder in mice and people that led to the identification of a gene vital for how T-regs operate.

"Their pioneering work has revealed how the immune system is kept in check by T-reg cells, preventing it from accidentally targeting the body's own tissues," said a prominent physiology specialist.

"The research is a striking example of how basic physiological study can have broad consequences for human health."